Markus Niederwanger, MD
Physical Medicine & Rehabilitation · Savannah, GANPI 1508858887
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,187 of the $11,977 with a category attached, or 76.7%. Boston Scientific accounts for 69.4% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2024 at $3,368 and has fallen 56.4% since, to $1,468 in 2025. Among physical medicine & rehabilitation clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 461 payments — averaging $25.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$8K
- Collegium Pharmaceutical, Inc.$624
- Scilex Pharmaceuticals Inc.$463
- Abbott$406
- Nevro Corp.$301
- SPR Therapeutics, Inc$271
- plus $2K from 22 others
What the payments were for
- Consulting fees$8257%
- Travel & lodging$1,96516%
- Food & beverage$9,18777%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 289 | $8,307 |
| Collegium Pharmaceutical, Inc. | 32 | $624 |
| Scilex Pharmaceuticals Inc. | 28 | $463 |
| Abbott | 23 | $406 |
| Nevro Corp. | 10 | $301 |
| SPR Therapeutics, Inc | 4 | $271 |
| Saluda Medical Americas, Inc. | 5 | $213 |
| AbbVie(2 entities) | 8 | $179 |
| Biodelivery Sciences International, Inc. | 12 | $173 |
| Forte Bio-pharma LLC | 7 | $172 |
| Sentynl Therapeutics, Inc. | 12 | $172 |
| Globus Medical | 4 | $108 |
| Vertex | 3 | $106 |
| Pfizer | 5 | $76 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $75 |
| Vertos Medical, Inc. | 2 | $66 |
| Amgen | 2 | $36 |
| Stryker | 1 | $33 |
| Avanos Medical | 1 | $28 |
| Pacira Therapeutics, Inc. | 1 | $24 |
| Painteq LLC | 1 | $23 |
| IBSA Pharma Inc. | 1 | $19 |
| Protega Pharmaceutials Inc | 1 | $18 |
| Medtronic | 1 | $18 |
| Shionogi Inc | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,977 in reported general payments places this provider in the 95th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 63 | $52,000 |
| Buprenorphine | 91 | $29,347 |
| RelistorMethylnaltrexone Bromide | 11 | $24,793 |
| Xtampza ErOxycodone Myristate | 26 | $23,241 |
| ButransBuprenorphine | 24 | $12,900 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 590 | $11,612 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 182 | $4,455 |
| Fentanyl | 24 | $3,065 |
| Lidocaine | 22 | $2,072 |
| Pregabalin | 54 | $1,660 |
| Morphine Sulfate ErMorphine Sulfate | 41 | $1,338 |
| Gabapentin | 78 | $1,269 |
| Baclofen | 101 | $986 |
| Tizanidine Hcl | 86 | $838 |
| Celecoxib | 26 | $782 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $624 | $75,24189 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $75 | $24,79311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 214 physical medicine & rehabilitation providers in Georgia.
Other physical medicine & rehabilitation in Savannah
- Ruben DiazSavannah$2K
- Jess ArcureSavannah$1K
- Erik ShawAtlanta$175K
- David TranAlpharetta$96K
- Payal FadiaDecatur$66K
- John MusserStockbridge$57K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald ChaiLawrenceville$16K
- Gerald BilskyAtlanta$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.